An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

Technology Advancement & Transfer - NIDDK

Home
Research & Funding
Technology Advancement & Transfer

Related Topics

Technology Advancement & Transfer

NIDDK is committed to transferring its technologies and research materials through industry partnerships to benefit public health. The NIDDK Technology Advancement Office (TAO) facilitates the exchange, evaluation, patenting, and licensing of new inventions and discoveries. If you have any questions, contact the Technology Advancement Office .

TAO Supports

Research Materials and Licensing
Use research materials and reagents, Material Transfer Agreements (MTAs), and licensing opportunities developed by NIDDK scientists for your research.
Clinical Trial Collaboration
Collaborate with investigators at the NIH Clinical Center and NIDDK extramural clinical networks on clinical trials.
Research Collaboration
Connect with NIDDK clinicians or scientists in your field and locate technologies available for further development.

NIDDK Technology Highlights

Bi-directional arrows connecting an Investigator, a Patient, and three separate Clinicians to a central representation of secure Patient Data.

Multiple Chronic Conditions e-Care Plan Applications These proof-of-concept, standards-based applications enable the capture and sharing of critical person-centered data across home, community, clinic, and research-based settings for individuals with multiple chronic conditions.

A diagram of A3 Adenosine Receptor Positive Allosteric Modulators

A3 Adenosine Receptor Positive Allosteric Modulators Invention relates to allosteric modulation of A3 adenosine receptor (A3AR).

Diagram of Heterocyclic P2Y14 Antagonists for the Treatment of Various Conditions

Heterocyclic P2Y14 Antagonists for the Treatment of Various Conditions Composition of highly selective P2Y14 receptor antagonists, as potential therapeutics for asthma, chronic pain, inflammation and diabetes and neurodegeneration.

PBWC Slider Image

Personalized Body Weight Management System A licensable system to establish, track and adjust clinical weight management interventions over time. Accounts for changes in human appetite, metabolism, and calorie expenditure. Builds on the research behind the Body Weight Planner.

A mouse with a DNA Helix symbol

Sphk1 KO A Sphingosine kinase 1 (Sphk1) knockout mouse…

Visual representation of the Stat5a LoxP/Stat5b LoxP protein.

Stat5a LoxP/Stat5b LoxP (Stat5a/Stat5b tm2Mam) Conditional knockout of Stat5a and Stat5b: Combined deletion of conserved Stat5a and Stat5b in mammary
epithelium at different times during pregnancy reveal multiple distinct functions...

Related Links

NIH Resources

Last Reviewed September 2024